Market Closed -
OTC Markets
11:58:07 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
0.0029
USD
|
+3.57%
|
|
+383.33%
|
+7.41%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
11.52
|
12.83
|
2.829
|
2.489
|
1.617
|
0.4089
|
Enterprise Value (EV)
1 |
9.283
|
12.91
|
8.06
|
11.05
|
8.171
|
7.439
|
P/E ratio
|
-10.6
x
|
-2.55
x
|
-0.7
x
|
-0.54
x
|
-0.68
x
|
-0.28
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
40,364,592
x
|
17,563,378
x
|
-
|
-
|
-
|
EV / Revenue
|
-
|
40,615,895
x
|
50,047,470
x
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-3,020,399
x
|
-2,666,618
x
|
-7,367,707
x
|
-8,506,712
x
|
-8,361,028
x
|
EV / FCF
|
-7.63
x
|
-2.64
x
|
-3.38
x
|
-2.98
x
|
-38.5
x
|
-12.1
x
|
FCF Yield
|
-13.1%
|
-37.9%
|
-29.6%
|
-33.5%
|
-2.6%
|
-8.27%
|
Price to Book
|
3.51
x
|
3.17
x
|
-3.15
x
|
-0.46
x
|
-0.32
x
|
-0.07
x
|
Nbr of stocks (in thousands)
|
28,653
|
37,276
|
37,714
|
39,034
|
41,878
|
58,004
|
Reference price
2 |
0.4022
|
0.3441
|
0.1018
|
0.0638
|
0.0386
|
0.007050
|
Announcement Date
|
9/18/18
|
10/28/19
|
10/15/20
|
10/6/21
|
10/27/22
|
9/21/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.3177
|
0.161
|
-
|
-
|
-
|
EBITDA
|
-
|
-4.273
|
-3.023
|
-1.5
|
-0.9605
|
-0.8897
|
EBIT
1 |
-0.7292
|
-4.549
|
-3.147
|
-1.605
|
-1.055
|
-0.9463
|
Operating Margin
|
-
|
-1,431.69%
|
-1,953.96%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.7385
|
-4.928
|
-5.453
|
-4.534
|
-2.351
|
-1.347
|
Net income
1 |
-0.7385
|
-4.665
|
-5.453
|
-4.534
|
-2.351
|
-1.347
|
Net margin
|
-
|
-1,468.23%
|
-3,386.19%
|
-
|
-
|
-
|
EPS
2 |
-0.0378
|
-0.1349
|
-0.1449
|
-0.1179
|
-0.0565
|
-0.0250
|
Free Cash Flow
1 |
-1.217
|
-4.895
|
-2.383
|
-3.702
|
-0.2125
|
-0.6149
|
FCF margin
|
-
|
-1,540.51%
|
-1,479.75%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/18/18
|
10/28/19
|
10/15/20
|
10/6/21
|
10/27/22
|
9/21/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.08
|
5.23
|
8.56
|
6.55
|
7.03
|
Net Cash position
1 |
2.24
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.0187
x
|
-1.731
x
|
-5.708
x
|
-6.823
x
|
-7.901
x
|
Free Cash Flow
1 |
-1.22
|
-4.89
|
-2.38
|
-3.7
|
-0.21
|
-0.61
|
ROE (net income / shareholders' equity)
|
-44.7%
|
-127%
|
-384%
|
137%
|
41.3%
|
20.9%
|
ROA (Net income/ Total Assets)
|
-21.8%
|
-36%
|
-20.5%
|
-17.9%
|
-22.7%
|
-39%
|
Assets
1 |
3.39
|
12.95
|
26.62
|
25.3
|
10.38
|
3.455
|
Book Value Per Share
2 |
0.1100
|
0.1100
|
-0.0300
|
-0.1400
|
-0.1200
|
-0.1100
|
Cash Flow per Share
2 |
0.0900
|
0.1900
|
0.0900
|
0.0100
|
0.0200
|
0.0100
|
Capex
1 |
1.06
|
1.74
|
0.17
|
0.06
|
-
|
-
|
Capex / Sales
|
-
|
546.7%
|
106.3%
|
-
|
-
|
-
|
Announcement Date
|
9/18/18
|
10/28/19
|
10/15/20
|
10/6/21
|
10/27/22
|
9/21/23
|
|
1st Jan change
|
Capi.
|
---|
| +7.41% | 225K | | +47.74% | 289M | | +30.93% | 270M | | +48.84% | 193M | | -14.29% | 145M | | +57.96% | 143M | | +147.89% | 141M | | -7.69% | 80.17M | | +150.00% | 75.33M | | +43.75% | 66.15M |
Medical Farming
|